文献速递骨肌技术与安全CTMRPET

多发性骨髓瘤的放射学影像:最新技术综述

Radiological imaging in multiple myeloma: review of the state-of-the-art.
PubMed 文献 · Neuroradiology · 2020-04-21

本文综述多发性骨髓瘤的放射学影像技术进展及主要表现,指出常规骨骼检查已逐渐被全身低剂量CT替代,MRI是检测骨骼及骨髓受累最敏感的技术,PET较CT敏感性更高但糖酵解通路相关基因低表达可致假阴性,仅联合多模态先进影像才能更好评估、分期及早期评价治疗反应。

要点

  • 全身低剂量CT已逐渐取代常规骨骼检查,可识别小溶骨性病变及髓内外受累。
  • MRI是检测多发性骨髓瘤骨骼及骨髓受累最敏感的影像技术。
  • PET较CT敏感性更高并提供定量数据,但糖酵解通路基因低表达可致假阴性。

核心结论

  • 仅使用先进联合多模态影像才能更好地评估、分期和早期评价多发性骨髓瘤患者的治疗反应。

研究设计与样本

  • 综述,回顾并总结多发性骨髓瘤的放射学技术及影像技术进展,并阐述不同影像技术在患者中的主要表现。

关键影像表现/征象

  • 全身低剂量CT可识别小溶骨性病变以及髓内和髓外受累。
  • MRI多参数评估(形态学、扩散加权和灌注成像序列)及定量分析有助于早期评价治疗反应。
  • PET提供定量数据,但糖酵解通路相关特定基因表达水平较低与假阴性结果相关,导致疾病低估。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Multiple myeloma is a type of blood cancer arising from the uncontrolled clonal proliferation of malignant plasma cells resulting in impaired hematopoiesis, hyper production of monoclonal protein, bone tissue destruction leading and renal system alterations up to kidney failure. The aim is to review the state-of-the-art of radiological imaging in multiple myeloma.

METHODS: Radiological techniques as well as the advancements in imaging technology have been reviewed and summarized. The main radiological findings of different imaging techniques in patients suffering from multiple myeloma are also illustrated.

RESULTS: Different radiological techniques provide structural and functional data. In the last years, conventional skeletal survey has gradually lost its utility and it has been replaced by whole body low-dose computed tomography which allows to identify also small lytic lesions, the medullary and the extramedullary involvement. Nowadays, magnetic resonance is the most sensitive imaging technique for detecting of skeletal as well as medullary involvement in patients with multiple myeloma. Thanks to the multiparametric evaluation (morphological, diffusion weighted and perfusion imaging sequences) and to the quantitative analysis, magnetic resonance imaging is proved to be useful in the early evaluation of response to therapy. Finally, positron emission tomography has greater sensibility compared to computed tomography as it provides quantitative data; however, the lower expression levels of the specific gene involved in the glycolysis pathway are associated with false-negative results with consequent underestimation of the disease.

CONCLUSION: The only use of the advanced combined multimodal imaging allows a better evaluation, staging and early assessment of treatment response in patients with multiple myeloma.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Di Giuliano F, Picchi E, Muto M, et al. Radiological imaging in multiple myeloma: review of the state-of-the-art. Neuroradiology. 2020. PMID: 32313979. doi:10.1007/s00234-020-02417-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。